• Home
  • About
  • FDA
    • EL-PFDD Meeting
    • Voice of Patient Report
  • Congress
    • Policy Priorities
    • Advocacy Day
    • Letters Supported
  • State
    • Medicaid
    • State Proclamations
  • Action Alerts
    • Current Action Alerts
    • Sign Up
  • Resources
  • Events
  • News
  • More
    • Home
    • About
    • FDA
      • EL-PFDD Meeting
      • Voice of Patient Report
    • Congress
      • Policy Priorities
      • Advocacy Day
      • Letters Supported
    • State
      • Medicaid
      • State Proclamations
    • Action Alerts
      • Current Action Alerts
      • Sign Up
    • Resources
    • Events
    • News
  • Home
  • About
  • FDA
    • EL-PFDD Meeting
    • Voice of Patient Report
  • Congress
    • Policy Priorities
    • Advocacy Day
    • Letters Supported
  • State
    • Medicaid
    • State Proclamations
  • Action Alerts
    • Current Action Alerts
    • Sign Up
  • Resources
  • Events
  • News
Lo

CURRENT ACTION ALERTS

National

FY27 Angelman syndrome advocacy day Asks

On March 4, 2026, 140 Angelman syndrome advocates went to Capitol Hill as a united front to urge elected officials to support our FY27 appropriations requests, keep us on the PRMRP list of eligible conditions for funding from the DoD, and urge the FDA to consider our patient experience data submitted November 2025 when reviewing new treathments.

Click here to take action today!

Sign Up for Action Alerts

By signing up below, you consent to being contacted by FAST and ASF via the contact information you provide. For a full disclosure of how your information is used, please refer to the privacy polices on the FAST and ASF website: https://cureangelman.org/policies and https://www.angelman.org/about/privacy/

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


Copyright © 2025 Hope in Action Advocacy Center - All Rights Reserved.


Email –  info@angelmanadvocates.org

  • FAST Policies
  • ASF Policies
  • Accessibility

Powered by

This website uses cookies.

We use essential cookies to make our site work. With your consent, we may also use non-essential cookies to improve user experience and analyze website traffic. 

DeclineAccept